Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Piafsky, O. Borgå, I. Odar-Cederlöf, C. Johansson, F. Sjöqvist (1978)
Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein.The New England journal of medicine, 299 26
E. L. Bierman (1982)
Textbook of MedicineBr. J. Prev. Soc. Med.
G. Mancini, A. Carbonara, J. Heremans (1965)
Immunochemical quantitation of antigens by single radial immunodiffusion.Immunochemistry, 2 3
(1981)
The endoplasmic reticulum: Its role in physiological functions and pathological situations
(1982)
Kinetics of induction of a, acid glycoprotein
W. Z. Billewicz, W. F. F. Kemsley, A. M. Thomson (1962)
Indices of adiposityAnn. Intern. Med., 16
P. Jackson, G. Tucker, H. Woods (1982)
Altered plasma drug binding in cancer: Role of α1‐acid glycoprotein and albuminClinical Pharmacology & Therapeutics, 32
G. Ricca, J. McLean, Johnm Taylor (1982)
KINETICS OF INDUCTION OF α1‐ACID GLYCOPROTEIN *Annals of the New York Academy of Sciences, 389
W. Billewicz, W. Kemsley, A. Thomson (1962)
Indices of AdiposityBritish Journal of Preventive & Social Medicine, 16
M. Mayersohn, J. Calkins, D. Perrier (1981)
Thiopental kinetics in obese surgical patientsAnesthesiology, 55
P. Jackson, G. Tucker, H. Woods (1982)
Altered plasma drug binding in cancer: role of alpha 1-acid glycoprotein and albumin.Clinical pharmacology and therapeutics, 32 3
Kinetics of induction of a
W. Hron, L. Menahan (1981)
A sensitive method for the determination of free fatty acids in plasma.Journal of lipid research, 22 2
D. Abernethy, D. Greenblatt, M. Divoll, J. Harmatz, R. Shader (1981)
Alterations in drug distribution and clearance due to obesity.The Journal of pharmacology and experimental therapeutics, 217 3
D. Abernethy, D. Greenblatt (1982)
Pharmacokinetics of Drugs in ObesityClinical Pharmacokinetics, 7
T. Gordon, W. Castelli, M. Hjortland, W. Kannel, T. Dawber, E. Newmark, Gretchen Williams, P. Shaw, D. Lyman, Ben Wood, C. Hibler, G. Hea, K. Macleod, Walter Stahl, G. Schultz, H. Boudoulas, R. Lewis, G. Dalamangas, D. Hirsch, F. Reubi, G. Massry, L. Yam, A. Chaudhry, A. Janckila, Michael Welsh, W. Svare (1977)
Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study.Annals of internal medicine, 87 4
K. M. Piafsky, O. Borga, I. Odar‐Cederlof, C. Johansson, F. Sjoqvist (1978)
Increased plasma protein binding of propranolol and chlorpromazine mediated by disease‐induced elevations of plasma alpha‐1‐acid glycoproteinEur. J. clin. Pharmac., 299
A. Gornall, C. Bardawill, M. David (1949)
Determination of serum proteins by means of the biuret reaction.The Journal of biological chemistry, 177 2
W. Kannel, T. Gordon, W. Castelli (1979)
Obesity, lipids, and glucose intolerance. The Framingham Study.The American journal of clinical nutrition, 32 6
I. Benedek, W. Fiske, W. Griffen, R. Bell, R. Blouin, P. McNamara (1983)
Serum alpha 1-acid glycoprotein and the binding of drugs in obesity.British journal of clinical pharmacology, 16 6
P. R. Jackson, G. T. Tucker, H. F. Woods (1982)
Altered plasma drug binding in cancer: Role of alpha1‐acid glycoprotein and albuminAm. J. clin. Nutr., 32
D. Abernethy, D. Greenblatt, M. Divoll, R. Shader (1982)
Prolongation of drug half-life due to obesity: studies of desmethyldiazepam (clorazepate).Journal of pharmaceutical sciences, 71 8
P. Routledge, D. Shand, A. Barchowsky, G. Wagner, W. Stargel (1981)
Relationship between alpha 1-acid glycoprotein and lidocaine disposition in myocardial infarction.Clinical pharmacology and therapeutics, 30 2
(1977)
Diabetes, blood lipids and role of obesity in coronary heart disease risk for women
(1949)
Determination of serum
M. J. Ridd, K. F. Brown, R. G. Moore, W. G. McBride, R. L. Nation (1982)
Diazepam plasma binding in the perinatal period: Influence of nonesterified fatty acidsJ. pharm. Sci., 22
Thomas Tozer, J. Gambertoglio, Daniel Furst, Denis Avery, Nicholas Holford (1983)
Volume shifts and protein binding estimates using equilibrium dialysis: application to prednisolone binding in humans.Journal of pharmaceutical sciences, 72 12
D. V. Parke (1981)
Concepts in Drug Metabolism Part BAnn. N.Y. Acad. Sci.
P. Routledge, D. Shand, A. Barchowsky, G. Wagner, W. Stargel (1981)
Relationship between α1‐acid glycoprotein and lidocaine disposition in myocardial infarctionClinical Pharmacology & Therapeutics, 30
W. T. Hron, L. A. Menahan (1981)
A sensitive method for the determination of free fatty acids in plasmaClin. Pharmac. Ther., 22
G. W. Snedecor, W. G. Cochran (1980)
Statistical Methods
A. G. Gornall, C. J. Bardawill, M. M. David (1949)
Determination of serum proteins by means of the Biuret reactionJ. Lipid Res., 177
Serum protein and lipid concentrations as well as the serum protein binding of propranolol, diazepam and phenytoin were measured in normal weight and obese volunteers. Concentrations of alpha 1‐acid glycoprotein (AAG) in the obese subjects were double that of the lean controls. Conversely, concentrations of high density lipoproteins (HDL) were decreased in the obese group. The serum binding of propranolol was increased in the obese subjects and correlated with serum AAG concentrations. Diazepam binding was slightly decreased in the obese as a result of lower serum albumin concentrations and elevated free fatty acids. The binding of phenytoin was comparable in all of the volunteers. These findings point out some of the complex pathophysiologic changes associated with obesity which may in turn influence drug disposition and hence drug therapy in the obese patient.
British Journal of Clinical Pharmacology – Wiley
Published: Dec 1, 1984
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.